SYNERCID® (quinupristin, dalfopristin) Patient information

SYNERCID® Quick Finder

Need Information on Pfizer’s Patient Assistance Programs?

Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. Patients and physicians can contact RxPathways at (866) 706-2400 or visit the website for more information on these programs www.pfizerrxpathways.com.
Have a Question about Pfizer Clinical Trials?

If you are looking for information about Pfizer studies currently recruiting new patients in your area, you can begin your search on our website. For questions about a Pfizer Clinical Trial, call (800) 718-1021 or email [email protected]
Need to report an Adverse Event, Side Effect, or Product Quality Concern?

Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product: (800) 438-1985

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns at 1-800-FDA-1088 or www.fda.gov/MedWatch
Resources

INDICATIONS AND USAGE

To reduce the development of drug-resistant bacteria and maintain the effectiveness of Synercid and other antibacterial drugs, Synercid should be used...

Did you find an answer to your question? Yes No

DOSAGE AND ADMINISTRATION

Synercid should be administered by intravenous infusion in 5% Dextrose in Water solution over a 60-minute period. (See WARNINGS...

Did you find an answer to your question? Yes No

CONTRAINDICATIONS

Synercid is contraindicated in patients with known hypersensitivity to Synercid, or with prior hypersensitivity to other streptogramins (...

Did you find an answer to your question? Yes No

WARNINGS

Drug Interactions

In vitro drug interaction studies have demonstrated that Synercid significantly...

Did you find an answer to your question? Yes No

ADVERSE REACTIONS

The safety of Synercid was evaluated in 1099 patients enrolled in 5 comparative clinical trials. Additionally, 4 non-comparative clinical trials (3 prospective and 1 retrospective...

Did you find an answer to your question? Yes No

OVERDOSAGE

There are four reports of patients receiving Synercid doses at up to three times that recommended (7.5 mg/kg). No adverse events were considered possibly or probably related to...

Did you find an answer to your question? Yes No

DESCRIPTION

Synercid® (quinupristin and dalfopristin powder for injection) I.V., a streptogramin antibacterial agent for intravenous administration, is a sterile lyophilized...

Did you find an answer to your question? Yes No

CLINICAL PHARMACOLOGY

Pharmacokinetics

Quinupristin and dalfopristin are the main active components circulating in plasma in human subjects. Quinupristin and...

Did you find an answer to your question? Yes No

CLINICAL STUDIES

COMPARATIVE TRIALS

Complicated Skin and Skin Structure Infections

Two randomized, open-label...

Did you find an answer to your question? Yes No

HOW SUPPLIED

Synercid is supplied as a sterile lyophilized pyrogen-free preparation in single-dose 10 mL type I glass vials with gray elastomeric closure, and aluminum seal with a dark blue flip-off...

Did you find an answer to your question? Yes No

To reduce the development of drug-resistant bacteria and maintain the effectiveness of Synercid and other antibacterial drugs, ...

Did you find an answer to your question? Yes No

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

To interact with the Medical Information Digital Assistant click here.

Call (800) 438-1985

Contact Pfizer Medical Information to speak with a professional regarding your medical question on a Pfizer prescription product: (800) 438-1985

Report Adverse Event

Pfizer Safety

To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this product, click the link below to submit your information: Pfizer Safety Reporting Site

*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.

If you cannot use the above website to report an adverse event related to a Pfizer product, please call Pfizer Medical Information at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatchor by calling
(800)-332-1088.